Send Inquiry

Request To Call Back

500 mg Dacarbazine Injection

Get a Price/Quote

MOQ : 100 Boxes

500 mg Dacarbazine Injection Specification

Life Span
24 months from manufacturing date

Dosage Form
Injection

Packaging Type
Glass Vial, Packaged in Box

Salt Composition
Dacarbazine

Indication
Malignant melanoma, Hodgkins lymphoma, and sarcoma

Pacakaging (Quantity Per Box)
1 vial per box

Brand Name
Dacarbazine Injection 500 mg

Drug Type
Prescription Allopathic

Ingredients
Dacarbazine 500 mg

Physical Form
Liquid (Injection) in glass vial

Function
Antineoplastic (anti-cancer) agent

Recommended For
Adults and pediatric patients as advised by physician

Dosage
As prescribed by the qualified healthcare provider

Dosage Guidelines
Administer intravenously according to medical guidelines

Suitable For
Cancer patients under supervision

Quantity
1 Vial

Storage Instructions
Store below 25C; protect from light

Marketed By
As per manufacturer's packaging

Intended Use
Hospital and oncology center supply only

Contraindications
Hypersensitivity to dacarbazine or any excipients

Strength
500 mg/vial

Regulatory Status
Prescription medicine, Schedule H

Precautions
Use under strict medical supervision; monitor blood counts

Reconstitution Directions
Reconstitute with sterile water for injection before administration

Therapeutic Class
Alkylating Agent (Cytotoxic)

Preservation
Keep container tightly closed to maintain sterility

Side Effects
Nausea, vomiting, liver toxicity, bone marrow suppression

Appearance
Sterile, lyophilized powder to be reconstituted with diluent

Route of Administration
Intravenous infusion only

Batch Number
As per packaging

Expiry Date
Stated on vial/pack

500 mg Dacarbazine Injection Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About 500 mg Dacarbazine Injection

Dacarbazine Injection 500 mg is a top-tier antineoplastic agent, crafted as a sterile, lyophilized powder for intravenous infusion use. This impeccable product, offered with competitive pricing, is customizable for bulk hospital and oncology center supply. It serves as a noble solution in the fight against malignant melanoma, Hodgkin's lymphoma, and sarcoma. Strictly for prescription use, Dacarbazine Injection 500 mg ensures safety and efficacy when administered under expert supervision. The glass vial packaging preserves sterility and provides reliability in storage and handling, promoting optimal therapeutic outcomes.

Clinical Applications and Material Features

Dacarbazine Injection 500 mg is intended exclusively for use in hospitals and oncology centers, catering to both adult and pediatric cancer patients. This prescription-only, allopathic formulation is reconstituted from a sterile, lyophilized powder to deliver precise, safe intravenous administration. Packaged in a robust glass vial, it ensures product integrity and stability throughout its lifespan. Administered by qualified healthcare professionals, this formulation is ideally suited for handling serious malignancies under stringent medical protocols.

Supply Offerings, Competitive Valuation, and Packaging Excellence

Dacarbazine Injection 500 mg is offered with remarkable supply ability to hospitals and medical distributors, both domestically and for export. Each vial is securely packed in a glass vial and boxed for impeccable safety during packing and dispatch. Our competitive pricing and reliable packaging details make it a preferred choice in key export markets worldwide. Rigorous attention to logistics ensures prompt and safe delivery, promoting value at every stage of procurement and distribution.

FAQ's of 500 mg Dacarbazine Injection:

Q: How should Dacarbazine Injection 500 mg be prepared before administration?

A: The injection must be reconstituted with sterile water for injection, following the provided directions, before being administered intravenously by a qualified healthcare professional.

Q: What is the recommended usage for Dacarbazine Injection 500 mg?

A: This medication is indicated for the treatment of malignant melanoma, Hodgkin's lymphoma, and sarcoma in hospital or oncology center settings, and should always be used under strict medical supervision.

Q: When should Dacarbazine Injection 500 mg be avoided?

A: This product is contraindicated in patients with known hypersensitivity to dacarbazine or any of its excipients. All allergy risks should be assessed prior to administration.

Q: Where can Dacarbazine Injection 500 mg be administered?

A: It is designed for intravenous administration only, and should be given in professional healthcare settings such as hospitals or oncology centers, by trained medical personnel.

Q: What are the main benefits of choosing this injectable formulation?

A: The product combines top-tier sterility and quality assurance, features competitive pricing, and offers customizable supply volumes for institutional needs, ensuring reliable therapeutic results in cancer management.

Tell us about your requirement